Neurolymphomatosis

03/01/2019 - "Limited efficacy of high-dose methotrexate in patients with neurolymphomatosis."
03/01/2009 - "We report the first case of neurolymphomatosis in a patient with Sézary syndrome and the partial efficacy of high-dose methotrexate sodium in treating this usually refractory complication. "
03/26/2021 - "The prognosis is generally poor but using high-dose methotrexate as well as high-dose chemotherapy and autologous stem cell transplantation may be an effective way to treat neurolymphomatosis."
07/01/2017 - "Treatment of neurolymphomatosis consists of focal radiotherapy and high-dose methotrexate therapy."
06/01/2004 - "High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis."

01/01/2021 - "Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era."
01/01/2021 - "Khurana A, Novo M, Nowakowski GS, et al. Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era. "
01/01/2020 - "Neurolymphomatosis was suspected, and the patient treated with rituximab with improvement. "
01/01/2016 - "(89) Zr-rituximab PET/CT to detect neurolymphomatosis."
02/01/2010 - "Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab."

01/01/2016 - "Here, we report the successful treatment of neurolymphomatosis caused by follicular lymphoma with bendamustine, which could be an effective treatment option for this condition. "
01/01/2016 - "A case of neurolymphomatosis caused by follicular lymphoma successfully treated with bendamustine."
01/01/2023 - "Polatuzumab vedotin plus bendamustine and rituximab (Pola-BR) was effective for neurolymphomatosis in a patient with refractory diffuse large B-cell lymphoma."

01/01/2021 - "Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis."

01/01/2023 - "Polatuzumab vedotin plus bendamustine and rituximab (Pola-BR) was effective for neurolymphomatosis in a patient with refractory diffuse large B-cell lymphoma."

07/01/2023 - "Bottle brush sign by 18F-FDG PET/CT in a patient with neurolymphomatosis."
10/19/2022 - "Neurolymphomatosis with Spinal Nerve Root Involvement Demonstrated on 18F-FDG PET/CT."
04/01/2022 - "Lumbosacral Plexus Neurolymphomatosis: A Typical 18FDG PET/CT Pattern to Recognize."
01/01/2022 - "18F-FDG PET/CT is a sensitive method for the diagnosis of neurolymphomatosis. "
09/01/2021 - "Utility of the 18F-FDG PET/CT in the diagnosis of the neurolymphomatosis: A case report."

08/01/2022 - "FDG-PET may be more sensitive to non-mass-forming lesions, including neurolymphomatosis, than gadolinium-contrast MRI."
01/01/2018 - "MR neurography criteria for the diagnosis of neurolymphomatosis include hyperintensity on T2 and STIR sequences, focal and diffuse nerve enlargement with fascicular disorganization and gadolinium enhancement. "
07/01/2015 - "In neurolymphomatosis (NL), the affected nerves are typically described to be enlarged and hyperintense on T2W MR sequences and to avidly enhance on gadolinium-enhanced T1WI. "

10/01/2019 - "Peripheral nerves can be damaged not only by the immunological targeting of the myelin by the paraprotein, but by deposition (light chain amyloid and cryoglobulins) or direct infiltration (neurolymphomatosis). "
01/01/2023 - "Neuropathy is a frequent complication of Waldenström's macroglobulinemia (WM), the most common being a demyelinating polyneuropathy with anti-myelin associated glycoprotein (MAG) antibodies, but also cryoglobulins, vasculitis, neurolymphomatosis, and amyloidosis. "

05/01/2019 - "Expression of CD56, synonymous with neural cell adhesion molecule, is rare in B-cell lymphomas and has not been reported in feline B-cell lymphomas or feline neurolymphomatosis. "

01/01/2023 - "Neuropathy is a frequent complication of Waldenström's macroglobulinemia (WM), the most common being a demyelinating polyneuropathy with anti-myelin associated glycoprotein (MAG) antibodies, but also cryoglobulins, vasculitis, neurolymphomatosis, and amyloidosis. "

05/01/2011 - "Value of FDG PET in the evaluation of therapy response in nerve root neurolymphomatosis."
08/01/2007 - "Sciatic nerve neurolymphomatosis - extent and therapy response assessment with PET/CT."
12/29/2019 - "This case highlights the diagnostic challenge in peripheral neurolymphomatosis related to patchy disease, variable sensitivity and specificity of investigative tools, and the influence of therapies on traditional cytological definitions of lymphoma. "
05/01/2023 - "Chimeric Antigen Receptor T-Cell Therapy of Neurolymphomatosis Monitored by FDG PET/CT."
02/01/2016 - "Neurolymphomatosis on 18F-FDG PET/CT: Diagnosis and Therapy Response."

01/01/2020 - "After 1 cycle of chemotherapy, the follow-up PET/CT showed markedly reduced FDG uptake in the previous involved nerves, demonstrating a very good response of neurolymphomatosis to chemotherapy. "
01/01/2019 - "Treatment options based on recommendations for people with neurolymphomatosis include systemic chemotherapy, intrathecal chemotherapy and/or localized radiation chemotherapy. "
01/01/2011 - "F-18 FDG PET/CT findings of a case of sacral nerve root neurolymphomatosis that occurred during chemotherapy."
08/01/2009 - "Reversal of neurological deficit after chemotherapy in BCL-6-positive neurolymphomatosis. "
07/01/2019 - "Included cases were biopsy-proven neurolymphomatosis or lymphoma patients with clinical and imaging evidence of neurolymphomatosis that resolved after chemotherapy. "

10/28/2022 - "Numerous factors can be implicated, such as central nervous system infiltrates, neurolymphomatosis, complications to medication or allogeneic stem cell transplantation, HAM/TSP, infections, metabolic disturbances. "
07/01/2023 - "Thiotepa-based high-dose chemotherapy with autologous stem cell transplantation for neurolymphomatosis."
03/26/2021 - "The prognosis is generally poor but using high-dose methotrexate as well as high-dose chemotherapy and autologous stem cell transplantation may be an effective way to treat neurolymphomatosis."
06/01/2004 - "High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis."

07/01/2019 - "B-cell neurolymphomatosis most commonly manifests as T2-weighted hyperintense, enhancing linear or fusiform neural enlargement associated with muscular denervation on MRI, with intense FDG activity on PET/CT. "
05/01/2019 - "Histologically, there was evidence of neurolymphomatosis (neurotropic lymphoma) with Wallerian degeneration and denervation atrophy of myofibres. "

03/01/2021 - "We present magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) findings of a 63-year-old female patient suffering from isolated neurolymphomatosis of cranial multineuritis with a wide constellation of syndromes including binocular diplopia, left facial paralysis and pain, syncope episodes, and progressive dysphagia. "